{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T10:26:14Z","timestamp":1777285574829,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1002\/hup.2557","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T04:33:23Z","timestamp":1479357203000},"page":"412-418","source":"Crossref","is-referenced-by-count":41,"title":["Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study"],"prefix":"10.1002","volume":"31","author":[{"given":"Pedro Damian","family":"Gargoloff","sequence":"first","affiliation":[{"name":"Hospital Alejandro Korn, Melchor Romero; La Plata Argentina"},{"name":"Clinica City Bell; La Plata Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Corral","sequence":"additional","affiliation":[{"name":"Departamento de Docencia e Investigacion; Hospital Jose T Borda; CABA Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Herbst","sequence":"additional","affiliation":[{"name":"Hospital Jose T. Borda; CABA Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Marquez","sequence":"additional","affiliation":[{"name":"ADINEU; CABA Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Imaging and Clinical Science; Chieti Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro Rafael","family":"Gargoloff","sequence":"additional","affiliation":[{"name":"Clinica City Bell; La Plata Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,16]]},"reference":[{"issue":"6","key":"10.1002\/hup.2557-BIB0001|hup2557-cit-0002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00210-003-0751-2","article-title":"New selective ligands of human cloned melatonin MT(1) and MT(2) receptors","volume":"367","author":"Audinot","year":"2003","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"issue":"Supp1","key":"10.1002\/hup.2557-BIB0002|hup2557-cit-0003","first-page":"15","article-title":"The noradrenergic symptom cluster: Clinical expression and neuropharmacol","volume":"7","author":"Blier","year":"2011","journal-title":"Neuropsychiatric Dis Treat"},{"key":"10.1002\/hup.2557-BIB0003|hup2557-cit-0004","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2710.2000.00302.x","article-title":"Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression","volume":"25","author":"Boyer","year":"2000","journal-title":"J Clin Pharmacy Therapeutics"},{"key":"10.1002\/hup.2557-BIB0004|hup2557-cit-0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/npp.2012.140","article-title":"Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine and serotonin systems in the rat brain","volume":"38","author":"Chenu","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/hup.2557-BIB0005|hup2557-cit-0006","first-page":"241","article-title":"Agomelatine for the treatment of posttraumatic stress disorder: A case report","volume":"24","author":"De Berardis","year":"2012","journal-title":"Annals of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/hup.2557-BIB0006|hup2557-cit-0007","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/039463201302600203","article-title":"Is there a role for agomelatine in the treatment of anxiety disorders? A review of published data","volume":"26","author":"De Berardis","year":"2013a","journal-title":"International Journal of Immunopathology and Pharmacology"},{"issue":"6","key":"10.1002\/hup.2557-BIB0007|hup2557-cit-0008","doi-asserted-by":"crossref","first-page":"12458","DOI":"10.3390\/ijms140612458","article-title":"The melatonergic system in mood and anxiety disorders and the role of agomelatine: Implications for clinical practice","volume":"14","author":"De Berardis","year":"2013b","journal-title":"Int J Molecular Sciences"},{"issue":"1","key":"10.1002\/hup.2557-BIB0008|hup2557-cit-0009","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3390\/ijms16011111","article-title":"Agomelatine beyond borders: Current evidences of its efficacy in disorders other than major depression","volume":"16","author":"De Berardis","year":"2015","journal-title":"Int J Molecular Sciences"},{"issue":"1","key":"10.1002\/hup.2557-BIB0009|hup2557-cit-0010","first-page":"109","article-title":"Major depressive disorder, anhedonia and agomelatine: An open-label study","volume":"25","author":"Di Giannantonio","year":"2011","journal-title":"Journal of Biological Regulators and Homeostatic Agents"},{"issue":"3","key":"10.1002\/hup.2557-BIB0049|hup2557-cit-0050","doi-asserted-by":"crossref","first-page":"S505","DOI":"10.1016\/j.euroneuro.2012.07.004","article-title":"Anhedonia and major depression: the role of agomelatine","volume":"22","author":"Di Giannantonio","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1-3","key":"10.1002\/hup.2557-BIB0010|hup2557-cit-0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jad.2012.10.004","article-title":"Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature?","volume":"147","author":"Di Nicola","year":"2013","journal-title":"J Affective Disorder"},{"key":"10.1002\/hup.2557-BIB0011|hup2557-cit-0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S41557","article-title":"Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: A preliminary open label study","volume":"9","author":"Fornaro","year":"2013","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1-3","key":"10.1002\/hup.2557-BIB0012|hup2557-cit-0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2006.08.020","article-title":"The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith-Hamilton Pleasure Scale (SHAPS","volume":"99","author":"Franken","year":"2007","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/hup.2557-BIB0013|hup2557-cit-0014","first-page":"227","article-title":"Translation into Spanish and validation of the Snaith-Hamilton Pleasure Scale (SHAPS) for anhedonia","volume":"41","author":"Fres\u00e1n","year":"2013","journal-title":"Actas Espa\u00f1olas de Psiquiatr\u00eda"},{"key":"10.1002\/hup.2557-BIB0014|hup2557-cit-0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7525-8-8","article-title":"Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool","volume":"8","author":"Garc\u00eda-Campayo","year":"2010","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1002\/hup.2557-BIB0015|hup2557-cit-0016","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.eurpsy.2012.11.004","article-title":"Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study with agomelatine and a global meta-analysis","volume":"28","author":"Gorwood","year":"2013","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/hup.2557-BIB0016|hup2557-cit-0017","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/WNF.0b013e3182800271","article-title":"A possible new option for migraine management: Agomelatine","volume":"36","author":"Guglielmo","year":"2013","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/hup.2557-BIB0017|hup2557-cit-0018","first-page":"218","volume-title":"The Clinical Global Impression Scale. In: ECDEU Assessment Manual for Psychopharmacology-Revised","author":"Guy","year":"1976"},{"key":"10.1002\/hup.2557-BIB0018|hup2557-cit-0019","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fpsyt.2011.00010","article-title":"Anhedonia and substance dependence: Clinical correlates and treatment options","volume":"2","author":"Hatzigiakoumis","year":"2011","journal-title":"Front Psychiatry"},{"key":"10.1002\/hup.2557-BIB0019|hup2557-cit-0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pbb.2015.05.021","article-title":"The effect of the antipsychotic drug quetiapine and its metabolite norquetiapine on acute inflammation, memory and anhedonia","volume":"135","author":"Jaehne","year":"2015","journal-title":"Pharmacology Biochemical Behaviors"},{"issue":"3","key":"10.1002\/hup.2557-BIB0020|hup2557-cit-0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/JCP.0b013e318172b48c","article-title":"double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR","volume":"28","author":"Kennedy","year":"2008","journal-title":"Journal Clinical Psychopharmacology"},{"key":"10.1002\/hup.2557-BIB0021|hup2557-cit-0022","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-015-0267-6","article-title":"Network metaanalysis and cost effectiveness analysis of new generation antidepressants","author":"Khoo","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1002\/hup.2557-BIB0022|hup2557-cit-0023","first-page":"1","volume-title":"Anhedonia and Affect Deficit States","author":"Klein","year":"1984"},{"issue":"5","key":"10.1002\/hup.2557-BIB0023|hup2557-cit-0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/0269881114568041","article-title":"Neural correlates of change in major depressive disorder anhedonia following open-label ketamine","volume":"29","author":"Lally","year":"2015","journal-title":"Journal Psychopharmacology"},{"issue":"2","key":"10.1002\/hup.2557-BIB0024|hup2557-cit-0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00952990701877078","article-title":"Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects","volume":"34","author":"Martinotti","year":"2008","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1002\/hup.2557-BIB0025|hup2557-cit-0026","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/JCP.0b013e31825d6c25","article-title":"Agomelatine versus venlafaxine XR in the treatment of anhedonia in major depressive disorder: A pilot study","volume":"32","author":"Martinotti","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/hup.2557-BIB0026|hup2557-cit-0027","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/13543784.2016.1175431","article-title":"Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives","volume":"25","author":"Martinotti","year":"2016a","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1002\/hup.2557-BIB0027|hup2557-cit-0028","first-page":"19(5)","article-title":"Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms","author":"Martinotti","year":"2016b","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/hup.2557-BIB0028|hup2557-cit-0029","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jaac.2012.01.011","article-title":"Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression","volume":"51","author":"McMakin","year":"2012","journal-title":"Journal of American Academy of Child and Adolescents Psychiatry"},{"key":"10.1002\/hup.2557-BIB0029|hup2557-cit-0030","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.103.051797","article-title":"The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways","volume":"306","author":"Millan","year":"2003","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1002\/hup.2557-BIB0030|hup2557-cit-0031","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.euroneuro.2014.03.008","article-title":"Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment","volume":"24","author":"Millan","year":"2014","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/hup.2557-BIB0031|hup2557-cit-0032","first-page":"271","article-title":"Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: A randomised, double-blind, placebo-controlled discontinuation study","volume":"19","author":"Montgomery","year":"2004","journal-title":"IntClinPsychopharmacol"},{"key":"10.1002\/hup.2557-BIB0032|hup2557-cit-0033","doi-asserted-by":"crossref","DOI":"10.1177\/0269881106069938","article-title":"The other face of depression, reduced positive affect: The role of cathecolamines in causation and cure","author":"Nutt","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/hup.2557-BIB0033|hup2557-cit-0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fpsyt.2014.00173","article-title":"Allostasis as a conceptual framework linking bipolar disorder and addiction","volume":"5","author":"Pettorruso","year":"2014a","journal-title":"Frontiers in Psychiatry"},{"issue":"2","key":"10.1002\/hup.2557-BIB0034|hup2557-cit-0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.psychres.2013.12.013","article-title":"Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study","volume":"215","author":"Pettorruso","year":"2014b","journal-title":"Psychiatry Research"},{"issue":"5","key":"10.1002\/hup.2557-BIB0035|hup2557-cit-0036","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1002\/hup.2557-BIB0036|hup2557-cit-0037","volume-title":"Kaplan and Sadock's Comprehensive Textbook of Psychiatry","year":"2009"},{"key":"10.1002\/hup.2557-BIB0037|hup2557-cit-0038","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0010-440X(97)90057-2","article-title":"Does anhedonia correlate with depression severity in chronic depression?","volume":"38","author":"Schrader","year":"1997","journal-title":"Comprehensive Psychiatry"},{"issue":"Suppl 20","key":"10.1002\/hup.2557-BIB0038|hup2557-cit-0039","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/hup.2557-BIB0039|hup2557-cit-0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"Scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale","volume":"167","author":"Snaith","year":"1995","journal-title":"The British Journal of Psychiatry"},{"issue":"10","key":"10.1002\/hup.2557-BIB0040|hup2557-cit-0041","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/hup.2557-BIB0041|hup2557-cit-0042","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S1092852914000248","article-title":"Mechanism of action of agomelatine: A novel antidepressant exploiting synergy between monoaminergic and melatonergic properties","volume":"19","author":"Stahl","year":"2014","journal-title":"CNS Spectrums"},{"key":"10.1002\/hup.2557-BIB0042|hup2557-cit-0043","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/hup.2294","article-title":"Efficacy of the novel antidepressant agomelatine on anxiety symptoms in major depression","volume":"28","author":"Stein","year":"2013","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1002\/hup.2557-BIB0043|hup2557-cit-0044","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g1888","article-title":"Antidepressant efficacy of agomelatine: Metaanalysis of published and unpublished studies","volume":"348","author":"Taylor","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/hup.2557-BIB0044|hup2557-cit-0045","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: Lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"1","key":"10.1002\/hup.2557-BIB0045|hup2557-cit-0046","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/hup.2557-BIB0046|hup2557-cit-0047","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"The American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/hup.2557-BIB0047|hup2557-cit-0048","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.biopsych.2012.10.014","article-title":"Reduced reward learning predicts outcome in major depressive disorder","volume":"73","author":"Vrieze","year":"2013","journal-title":"Biological Psychiatry"},{"key":"10.1002\/hup.2557-BIB0048|hup2557-cit-0049","unstructured":"World Health Organization The global burden of disease 2004 http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GBD_report_2004update_full.pdf"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2557","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2557","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hup.2557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T22:34:45Z","timestamp":1533594885000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/hup.2557"}},"subtitle":["Efficacy of agomelatine on anhedonia: real-world study"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2557","archive":["Portico"],"relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}